ely and associates corp.

111 eighth avenue
new york, new york 10011

NYS Entity Status
ACTIVE

NYS Filing Date
AUGUST 21, 2013

NYS DOS ID#
4448501

County
NEW YORK

Jurisdiction
DELAWARE

Registered Agent
C T CORPORATION SYSTEM
111 EIGHTH AVENUE
NEW YORK, NEW YORK, 10011

NYS Entity Type
FOREIGN BUSINESS CORPORATION

Name History
2013 - ELY AND ASSOCIATES CORP.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Greg David on NY: Why developing in Midtown remains a Herculean task
    Monday Jun 19, 2017



    To view the full story, click the title link.

    Source: Crain&apso;s New York Business
  • Five Sites of New York’s L.G.B.T. History
    Monday Jun 19, 2017

    Jacob Riis Park, a Manhattan church, the Bum Bum Bar and more. In 360 degrees, visit five sites that helped shape New York City’s L.G.B.T. community and its history.

    Source: NYT > Home Page
  • Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
    By LIAM STACK - Monday Jun 19, 2017

    The gay bar’s 1969 patron-police battle, hailed as a starting point, actually followed many events in the city, now mapped in a sites project.

    Source: NYT > Home Page
  • New York City and James Blake Resolve Excessive-Force Claim
    By BENJAMIN MUELLER - Wednesday Jun 21, 2017

    As part of the deal with the former pro tennis player, the city will create a new position within the agency that investigates police misconduct.

    Source: NYT > Home Page
  • Ask the NY Giants: Socks with Sandals?
    Tuesday Sep 15, 2015

    Professional athletes like members of the New York Giants are the inspiration for the latest (counterintuitive) high-fashion trend: wearing socks with sandals. Photo: Stu Woo/The Wall Street Journal

    Source: The Wall Street Journal: Most Popular
  • Teva Seeks to Keep Pace in Migraine Drug Race With Trial Results
    By Frank Vinluan - Wednesday May 31, 2017

    An experimental Teva Pharmaceutical migraine drug has met the main goals of a late-stage clinical trial, keeping the drugmaker in the race to bring to the market a product that prevents migraine headaches instead of treating them after they start. Teva (NYSE: TEVA) reported Wednesday that its drug fremanezumab reduced the number of days during […]

    Source: Xconomy New York
  • Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs
    By Frank Vinluan - Wednesday Jun 14, 2017

    The IPO window is still open for clinical-stage drug companies, and Athenex is now the latest one to pass through it. The cancer drug developer raised $66 million through a public stock offering on Wednesday, funding that the company will devote mostly to a pair of cancer drugs in late-stage clinical development. Athenex priced its […]

    Source: Xconomy New York
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York